🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

THREAD: 59 Stanford athletes competed in #Paris2024 bringing home 39 total medals (36 for Team USA). Here's some more about what these incredible Stanford Cardinal 🌲🤓 athletes just accomplished.

Thank you to ICCS_Education for the opportunity to highlight efforts to improve toxicities and outcomes after CAR T-cell therapy! #FlowICCS2024 Jordan Gauthier Fred Hutch Cancer Center UW Medicine

🩸 ASH is launching CHAMP to support career growth and development in #hematology! Join our town hall on Nov 8 at 12 noon ET to learn more about this exciting new program. RSVP today! Register now: ow.ly/alNg50TM6Wu #Mentorship #Fellows #ASHTrainee

What will be your hematology success story? Apply for research funding and mentorship for #MedicalStudents #Residents and #DoctoralStudents. Learn more about these awards: ow.ly/zHCB50TujAe #ASHTrainee

Very excited to share our work led by Emily Liang just published in Blood Advances! doi.org/10.1182/blooda… We used the {tidymodels} framework in R to develop models (eIPM) predictive of hematotoxicity in CAR T-cell therapy recipients. Models performed well in our independent

Are you a trainee coming to #ASH24? Come say hi tomorrow 12/6 at ASH-a-Palooza! I will be participating in the speed mentoring session from 1:30-3:50pm as a🩸buddy. Let's chat about biostats/ML, CAR T-cell therapy, or #academicmedicine in general 😎 More info at:

A lot of talent in this group! The Fred Hutch/UW Hematology-Oncology Fellows checking out our booth (3205) at #ASH24. Stop by to hear about the latest in the #PNW!

Fresh off the press! Very happy to share our new publication in Blood Advances: Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients doi.org/10.1182/blooda… **SPOILER**: it's a bit of a "negative" study, but please read on 😄 I

Honored to have had the opportunity to work with Dr. Emily Liang on so many exciting projects. She is giving her Clinician Scholar Seminar talk today! Fred Hutch Cancer Center UW Medicine #proudmentor Ryan Cassaday

Fred Hutch at #Tandem25: Catch presentations from Drs. Monica Thakar, Cecilia Yeung, Emily Liang and Vicky Wu this afternoon at the annual Tandem Meetings of ASTCT and CIBMTR. Details: bit.ly/4jWtGLs

Meet the next generation of hematology and oncology leaders! The Fred Hutch/UW Hematology-Oncology Fellows are at #Tandem25 presenting their latest findings in transplantation, cell therapies, immunology and more. Emily Liang Hannah Abrams

1/5. Excited to share our new Haematologica paper comparing real-world outcomes of liso-cel vs axi-cel in LBCL using IPTW to mitigate treatment allocation bias. Comparable efficacy but higher toxicity with axi-cel. 🧵👇 haematologica.org/article/view/1… Fred Hutch Cancer Center UW Medicine

👂Tune in to the latest IACH NEWS podcast: Development and validation of predictive models of early immune effector cell–associated hematotoxicity by Dr. Emily Liang ⬇️⬇️ iach.org/iach-news-podc… Emily Liang Mohamad Mohty Arnon Nagler

Live from the Fred Hutch Cancer Center UW Medicine Hematology and Oncology Research Retreat! Excellent talk from Dr. Emily Liang presenting our prophylactic anakinra trial to prevent toxicities associated with liso-cel in LBCL patients.

🚨 5-year follow-up from a phase 1 trial of FCARH143, a fully human anti-BCMA CAR-T for relapsed/refractory #MultipleMyeloma 🔬 Let’s dive into the results from this study conducted at Fred Hutch Cancer Center & UW Medicine 🧵

So proud of our mentees graduating from our Fred Hutch Cancer Center University of Washington Hematology Oncology Fellowship program! 🎊🥳 Emily Liang Jennifer Huang